| 製品名 |
Irinotecan HCL |
| 英語名 |
Irinotecan HCL; Irinotecan, Hydrochloride; Irinotecan Hydrochloride; (S)-[1,4'-Bipiperidine]-1'-Carboxylic Acid, 4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester Hydrochloride; (S)-4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester; Topotecin Hydrochloride;
; (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride trihydrate; (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate; (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride (1:1) |
| 分子式 |
C33H39ClN4O6 |
| 分子量 |
623.139 |
| InChI |
InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1 |
| CAS登録番号 |
100286-90-6 |
| 分子構造 |
|
| 融点 |
250-256℃ (dec.) |
| 沸点 |
873.4°C at 760 mmHg |
| 引火点 |
482°C |
| 蒸気圧 |
1.31E-32mmHg at 25°C |
| ハザードシンボル |
|
| リスクコード |
|
| 安全説明 |
|
|
